Aethlon Medical, Inc.

breast cancer cancer darpa hcv sepsis medica innovation exosome her2 metastatis exosomes her+ infectious disease hiv nci hepatitis c investing sto fda nih aemd government contract award her2osome hepatitis aids hemopurifier adapt aethlon barda smallpox hhs influenza bioterror military obama niaid pandemic threats biodefense treatment countermeasure white house ebola